Back | Next |
home / stock / tlsa / tlsa message board
Subject | By | Source | When |
---|---|---|---|
$TLSA MomentumIts now | Count Crypto | investorshub | 09/18/2023 2:13:44 AM |
$TLSA The now | mfayman | investorshub | 09/18/2023 1:19:00 AM |
short squeeze | Anita Dump | investorshub | 09/18/2023 1:13:44 AM |
$TLSA Price trading last up | Count Crypto | investorshub | 09/18/2023 12:44:29 AM |
$TLSA news out | TREND1 | investorshub | 09/17/2023 10:43:37 PM |
Do we have a winner?Turn around time? | mfayman | investorshub | 09/17/2023 8:56:15 PM |
$TLSA is it bear time? Or do we go bull? | Ryguy008 | investorshub | 09/17/2023 7:35:42 PM |
The gaining | The Night Stalker | investorshub | 09/17/2023 6:49:58 PM |
$TLSA oh yeah news for the day | EOT | investorshub | 09/17/2023 5:00:01 PM |
$TLSA must see | mfayman | investorshub | 09/17/2023 4:49:49 PM |
The now | Crusader | investorshub | 09/17/2023 2:34:56 PM |
$TLSA MomentumIts gaining | Ryguy008 | investorshub | 09/17/2023 1:13:00 PM |
$TLSA Time for this to show some returns | Count Crypto | investorshub | 09/17/2023 12:04:33 PM |
great news | Crusader | investorshub | 09/17/2023 11:20:21 AM |
$TLSA short squeeze article | TREND1 | investorshub | 09/17/2023 8:58:36 AM |
here we go bulls news is here | Anita Dump | investorshub | 09/17/2023 8:25:29 AM |
are we finally gonna see some action | Crusader | investorshub | 09/17/2023 8:16:11 AM |
$TLSA should we be shorting? | TREND1 | investorshub | 09/17/2023 6:46:45 AM |
$TLSA The now | mfayman | investorshub | 09/17/2023 6:26:06 AM |
MomentumIts gaining last up | mfayman | investorshub | 09/17/2023 5:57:12 AM |
News, Short Squeeze, Breakout and More Instantly...
Tiziana Life Sciences plc Company Name:
TLSA Stock Symbol:
NASDAQ Market:
Tiziana Life Sciences plc Website:
NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, ant...
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough therapies in neurodegenerative disease secondary to active neuroinflammatory processes today announced t...
--News Direct-- Tiziana Life Sciences Ltd (NASDAQ:TLSA) chairman and CEO Gabriele Cerrone joined Proactive's Stephen Gunnion with more details of the company's recent advancements and news. Tiziana Life Sciences is developing a fully human CD3 monoclonal antibody, delivered intranasally, ...